Exosome engineering: a promising step toward cancer therapeutics

被引：2
作者：
Jayaseelan, Vijayashree Priyadharsini [1 ]
Arumugam, Paramasivam [2 ]
机构：
[1] Saveetha Univ, Saveetha Inst Med & Tech Sci, Saveetha Dent Coll & Hosp, Clin Genet Lab,Ctr Cellular & Mol Res, Chennai 77, Tamil Nadu, India
[2] Saveetha Univ, Saveetha Inst Med & Tech Sci, Saveetha Dent Coll & Hosp, Mol Biol Lab,Ctr Cellular & Mol Res, Chennai 77, Tamil Nadu, India
来源：
EPIGENOMICS | 2022年 / 14卷 / 09期
关键词：
artificial organelles; cancer; cardiovascular diseases; exosomes; miRNA; nucleic acid therapeutics; siRNA; stem cells; targeted therapy; translational medicine; DELIVERY; GROWTH; CELLS;
D O I：
10.2217/epi-2021-0474
中图分类号：
Q3 [遗传学];
学科分类号：
071007 ; 090102 ;
摘要：
引用
收藏
页码：503 / 506
页数：4
相关论文
共 14 条
[1]   Exosome-derived ncRNAs as potential drivers of epigenetic reprogramming of cancer stem cells [J].
Jayaseelan, Vijayashree Priyadharsini ;
Arumugam, Paramasivam .
EPIGENOMICS, 2021, 13 (18) :1439-1442
[2]   Exosomal microRNAs as a promising theragnostic tool for essential hypertension [J].
Jayaseelan, Vijayashree Priyadharsini ;
Arumugam, Paramasivam .
HYPERTENSION RESEARCH, 2020, 43 (01) :74-75
[3]   Dissecting the theranostic potential of exosomes in autoimmune disorders [J].
Jayaseelan, Vijayashree Priyadharsini ;
Arumugam, Paramasivam .
CELLULAR & MOLECULAR IMMUNOLOGY, 2019, 16 (12) :935-936
[4]   Therapeutic Potential of Nucleic Acids when Combined with Extracellular Vesicles [J].
Jurgielewicz, Brian ;
Stice, Steven ;
Yao, Yao .
AGING AND DISEASE, 2021, 12 (06) :1476-1493
[5]   Engineered exosomes delivering specific tumor-suppressive RNAi attenuate oral cancer progression [J].
Kase, Yutaro ;
Uzawa, Katsuhiro ;
Wagai, Sho ;
Yoshimura, Shusaku ;
Yamamoto, Jun-Ichiro ;
Toeda, Yuriko ;
Okubo, Megumi ;
Eizuka, Keitaro ;
Ando, Toshiaki ;
Nobuchi, Takafumi ;
Kawasaki, Kohei ;
Saito, Tomoaki ;
Iyoda, Manabu ;
Nakashima, Dai ;
Kasamatsu, Atsushi ;
Tanzawa, Hideki .
SCIENTIFIC REPORTS, 2021, 11 (01)
[6]   Exosomes: Cell-Derived Nanoplatforms for the Delivery of Cancer Therapeutics [J].
Kim, Hyosuk ;
Kim, Eun Hye ;
Kwak, Gijung ;
Chi, Sung-Gil ;
Kim, Sun Hwa ;
Yang, Yoosoo .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (01) :1-23
[7]   Programmed exosome fusion for energy generation in living cells [J].
Kumar, Sumit ;
Karmacharya, Mamata ;
Michael, Issac J. ;
Choi, Yongjun ;
Kim, Junyoung ;
Kim, InUn ;
Cho, Yoon-Kyoung .
NATURE CATALYSIS, 2021, 4 (09) :763-+
[8]   Delivery of vascular endothelial growth factor (VEGFC) via engineered exosomes improves lymphedema [J].
Li, Bohan ;
Yang, Jiantao ;
Wang, Raoping ;
Li, Jia ;
Li, Xubo ;
Zhou, Xiang ;
Qiu, Shuai ;
Weng, Ricong ;
Wu, Zichao ;
Tang, Chunyuan ;
Li, Ping .
ANNALS OF TRANSLATIONAL MEDICINE, 2020, 8 (22)
[9]   Engineered exosomes for targeted co-delivery of miR-21 inhibitor and chemotherapeutics to reverse drug resistance in colon cancer [J].
Liang, Gaofeng ;
Zhu, Yanliang ;
Ali, Doulathunnisa Jaffar ;
Tian, Tian ;
Xu, Huantian ;
Si, Ke ;
Sun, Bo ;
Chen, Baoan ;
Xiao, Zhongdang .
JOURNAL OF NANOBIOTECHNOLOGY, 2020, 18 (01)
[10]   Engineered exosome-mediated delivery of functionally active miR-26a and its enhanced suppression effect in HepG2 cells [J].
Liang, Gaofeng ;
Kan, Shu ;
Zhu, Yanliang ;
Feng, Shuying ;
Feng, Wenpo ;
Gao, Shegan .
INTERNATIONAL JOURNAL OF NANOMEDICINE, 2018, 13 :585-599
12